SCHEMBL4843849

SCHEMBL4843849

COc1cc(OC)cc(C(=O)Nc2cccc(C(=O)C=C3NC(C)(C)Cc4ccc(OC)cc43)c2)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.51
MEN1 O00255 3/20 0.51
MAPK1 P28482 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
NPC1 O15118 5/20 0.46
RAB9A P51151 4/20 0.46
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
TP53 P04637 2/20 0.45
KCNK9 Q9NPC2 3/20 0.43
KCNK3 O14649 2/20 0.43
TSHR P16473 2/20 0.43
MAPT P10636 2/20 0.43
RXFP1 Q9HBX9 1/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
NLRP3 Q96P20 1/20 0.43
PKM P14618 1/20 0.43
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4843839 1.00 KMT2A (0.51) KMT2AMEN1MAPK1L3MBTL1NPC1
SCHEMBL4837732 0.95 RAB9A (0.52) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL4837741 0.95 RAB9A (0.52) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL4839736 0.94 RAB9A (0.51) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL4839725 0.94 RAB9A (0.51) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL4843742 0.92 RAB9A (0.47) KMT2AMEN1MAPK1L3MBTL1NPC1
SCHEMBL4843729 0.92 RAB9A (0.47) KMT2AMEN1MAPK1L3MBTL1NPC1
SCHEMBL4844272 0.92 RXFP1 (0.55) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL4844284 0.92 RXFP1 (0.55) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL4835392 0.91 NPC1 (0.41) KMT2AMEN1MAPK1L3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US claimed
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 KMT2A 4642/4885MEN1 1230/4885MAPK1 635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.